Hydrogen Peroxide

Hydrogen Peroxide

SCHEMBL3679819

OO.c1ccc(C2CCCCC2)c(C2CCCCC2)c1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.55
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PTGS2 P35354 1/20 0.44
KMO O15229 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
SLC18A3 Q16572 1/20 0.41
HPGD P15428 1/20 0.41
CYP19A1 P11511 1/20 0.41
GAA P10253 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
CEL P19835 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL11398422 1.00 PTGDR2 (0.55) PTGDR2MEN1KMT2APTGS2KMO
SCHEMBL42781 0.95 PTGDR2 (0.48) PTGDR2PTGS2BCHEACHECHRNB4
SCHEMBL779938 0.92 CHRNB4 (0.46) PTGDR2MEN1KMT2APTGS2BCHE
SCHEMBL28904978 0.87 PTGDR2 (0.44) PTGDR2PTGS2BCHEACHECHRNB4
SCHEMBL11704954 0.84 CHRNB4 (0.52) PTGDR2MEN1KMT2APTGS2BCHE
SCHEMBL11701290 0.84 CHRNB4 (0.52) PTGDR2MEN1KMT2APTGS2BCHE
SCHEMBL2913620 0.83 CHRNB4 (0.44) PTGDR2PTGS2CHRNB4CHRNA3
SCHEMBL4960570 0.83 KMT2A (0.55) PTGDR2MEN1KMT2APTGS2BCHE
SCHEMBL4556222 0.83 KMT2A (0.55) PTGDR2MEN1KMT2APTGS2BCHE
SCHEMBL4959102 0.83 KMT2A (0.55) PTGDR2MEN1KMT2APTGS2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063329-A1 METHOD FOR DECOMPOSING DI(PHENYLALKYL)PEROXIDES TO PRODUCE HYDROXYBENZENES AND PHENYLALKENES USING SOLID CATALYSTS SHELL OIL COMPANY 2010-03-11 US disclosed
WO-2007137020-A2 METHOD FOR DECOMPOSING DI(PHENYLALKYL)PEROXIDES TO PRODUCE HYDROXYBENZENES AND PHENYLALKENES USING SOLID CATALYSTS SHELL OIL COMPANY (US) 2007-11-29 WO disclosed
US-4282383-A FREE RADICAL CATALYST; TERTIARY-BUTYL, CUMENE OR P-DIISOPROPYLBENZENE HYDROPEROXIDE THE UPJOHN COMPANY (US) 1981-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063329-A1 METHOD FOR DECOMPOSING DI(PHENYLALKYL)PEROXIDES TO PRODUCE HYDROXYBENZENES AND PHENYLALKENES USING SOLID CATALYSTS HAO2, HDHD5, PPOX PTGDR2 1435/4885MEN1 4520/4885KMT2A 1688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.